Literature DB >> 2526949

The involvement of dopamine D1 and D2 receptors in the locomotor stimulation produced by (+)-amphetamine in naive and dopamine-depleted mice.

S B Ross1, D M Jackson, S R Edwards.   

Abstract

The interaction between (+)-amphetamine and dopamine (DA) D1 and D2 receptors was investigated. In naïve mice, i.e., mice with intact stores of DA, both the selective D1 antagonist SCH23390 and the selective D2 antagonist spiperone blocked the locomoter stimulation produced by (+)-amphetamine. The selective D1 agonist SKF38393 (6 mg/kg intraperitoneally) did not produce a consistent dose-dependent effect on the response to (+)-amphetamine in naïve mice. In mice depleted of DA with reserpine 24 hr before a challenge with (+)-amphetamine, neither SCH23390 nor spiperone were completely effective in blocking (+)-amphetamine. A combination of spiperone plus SCH23390 was, however, more effective than either drug alone, although significant activity remained even after the combination. In mice pretreated with reserpine and various doses of alpha methyl-p-tyrosine (alpha MPT, intraperitoneally), the degree of stimulation produced by (+)-amphetamine was dependent on the amount and frequency of alpha MPT dosage - the higher and more frequent the dose, the more effective the blockade. In these animals, both SKF38393 and the selective D2 agonist quinpirole potentiated the stimulation induced by (+)-amphetamine when the dose of alpha MPT was not maximal. However, in those animals pretreated with reserpine plus two doses each of 400 mg/kg alpha MPT, neither SKF38393 nor quinpirole were effective in potentiating (+)-amphetamine. Nevertheless, when SKF38393 and quinpirole were administered simultaneously to these mice, marked locomotor stimulation occurred implying that the pretreatment itself had not rendered the mice incapable of locomotion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2526949     DOI: 10.1111/j.1600-0773.1989.tb00604.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  6 in total

1.  Effects of selective D1 and D2 dopamine antagonists on the development of behavioral sensitization to apomorphine.

Authors:  B A Mattingly; J K Rowlett; J T Graff; B J Hatton
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Behavioural, biochemical and electrophysiological studies on the motor depressant and stimulant effects of bromocriptine.

Authors:  D M Jackson; L P Martin; L G Larsson; R F Cox; B L Waszczak; S B Ross
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

3.  Dopamine antagonist effects on locomotor activity in naive and ethanol-treated FAST and SLOW selected lines of mice.

Authors:  E H Shen; J C Crabbe; T J Phillips
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

4.  Restoration of amphetamine-induced locomotor sensitization in dopamine D1 receptor-deficient mice.

Authors:  Mufida B El-Ghundi; Theresa Fan; Joanna M Karasinska; John Yeung; Millee Zhou; Brian F O'Dowd; Susan R George
Journal:  Psychopharmacology (Berl)       Date:  2009-10-15       Impact factor: 4.530

5.  Synergistic interactions between the NMDA antagonist dizocilpine and the preferential dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 with regard to locomotor stimulation in monoamine-depleted mice.

Authors:  A Svensson; M Carlsson; A Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1991

6.  Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release.

Authors:  Anne S Berry; Vyoma D Shah; Daniella J Furman; Robert L White; Suzanne L Baker; James P O'Neil; Mustafa Janabi; Mark D'Esposito; William J Jagust
Journal:  Neuropsychopharmacology       Date:  2017-08-17       Impact factor: 7.853

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.